BMO Capital raised the firm’s price target on Legence (LGN) to $46 from $36 and keeps an Outperform rating on the shares. Legence’s inaugural quarterly results following the IPO were strong across the board and were augmented by attractive M&A transactions that will add about 30% to pro forma revenues, the analyst tells investors in a research note.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LGN:
- Legence price target raised to $48 from $36 at RBC Capital
- Legence price target raised to $46 from $37 at Goldman Sachs
- Legence price target raised to $37 from $34 at Barclays
- Legence price target raised to $45 from $40 at BTIG
- Legence Corp. Receives Buy Rating Amid Strong Financial Performance and Strategic Growth Initiatives